Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...

Companies like AstraZeneca and GSK, which have high-revenue-generating inhalers for asthma and chronic obstructive pulmonary disorder (COPD ... choosing the best therapy for each patient.

Medically reviewed by Sanja Jelic, MDMedically reviewed by Sanja Jelic, MD Chronic obstructive pulmonary disease (COPD), an ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... COPD under a 510(k) over-the-counter ...